MDCG guidance
Q&A: Q&A on transitional provisions for products without an intended medical purpose covered by annex XVI of the MDR
MDCG guidance · Annex XVI products · September 2023
Key facts
| Reference | Q&A |
|---|---|
| Title | Q&A on transitional provisions for products without an intended medical purpose covered by annex XVI of the MDR |
| Topic | Annex XVI products |
| Published | September 2023 |
| Document | health.ec.europa.eu |
At a glance
- Yes Full text searchable in Orca1
- Q&A (September 2023) Revisions on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About MDCG guidance documents
The Medical Device Coordination Group (MDCG), made up of EU member-state experts, endorses guidance on applying the Medical Devices Regulation (EU) 2017/745 and the In Vitro Diagnostic Regulation (EU) 2017/746. Each page here covers one document and all of its revisions.